Literature DB >> 32780169

[Discharge management in pediatric and adolescent psychiatry : Expectations and realities from the parental perspective].

I Boege1,2, B Williams3, U Schulze3,4, J M Fegert3.   

Abstract

BACKGROUND: Interface management after inpatient care for mentally ill children and adolescents has been proven to be a breaking point in good transition of care between child and adolescent psychiatry, social welfare services, schools, job centre and the judicial system. Criteria for successful discharge management do not exist in child and adolescent psychiatry. Aim of the study ASpeKT was to survey parents on their perception of interface management and to derive recommendations for discharge management.
METHODS: Data regarding interface management were retrieved from parents (T3, n = 124, T4, n = 81) 6 months (T3) and 12 months (T4) after discharge.
RESULTS: The parents stated that accessible help after discharge from inpatient treatment is essential for stability and requires a good coordination. Parents named that they perceived helpful for successful interface management: a case manager, early round table meetings, support in returning to school, seamless access to outpatient follow-up appointments as well as information on further treatment options and contact data.
CONCLUSION: From the perspective of affected families a proactive early individual and reliable care coordination by a constant contact person is essential for a good discharge management.

Entities:  

Keywords:  Children and adolescents; Coordination; Interface management; Mental health; Provision of care

Mesh:

Year:  2021        PMID: 32780169      PMCID: PMC7943505          DOI: 10.1007/s00115-020-00974-1

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  9 in total

1.  [The KiGGS study. Nationwide representative longitudinal and cross-sectional study on the health of children and adolescents within the framework of health monitoring at the Robert Koch Institute].

Authors:  H Hölling; R Schlack; P Kamtsiuris; H Butschalowsky; M Schlaud; B M Kurth
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2012-06       Impact factor: 1.513

2.  Effectiveness of the wraparound process for children with emotional and behavioral disorders: a meta-analysis.

Authors:  Jesse C Suter; Eric J Bruns
Journal:  Clin Child Fam Psychol Rev       Date:  2009-12

3.  The measurement of observer agreement for categorical data.

Authors:  J R Landis; G G Koch
Journal:  Biometrics       Date:  1977-03       Impact factor: 2.571

4.  [School escorts in inclusive education- the current situation in the state of Baden-Wurttemberg].

Authors:  Katharina Henn; Leonore Thurn; Tanja Besier; Anne K Künster; Jörg M Fegert; Ute Ziegenhain
Journal:  Z Kinder Jugendpsychiatr Psychother       Date:  2014-11

5.  Prevalence of emotional and behavioural disorders in German children and adolescents: a meta-analysis.

Authors:  Claus Barkmann; Michael Schulte-Markwort
Journal:  J Epidemiol Community Health       Date:  2010-10-01       Impact factor: 3.710

Review 6.  [Inclusion - pediatric and adolescent psychiatry aspects].

Authors:  Andreas Warnke
Journal:  Z Kinder Jugendpsychiatr Psychother       Date:  2015-07

7.  Prevalence of mental health problems among children and adolescents in Germany: results of the BELLA study within the National Health Interview and Examination Survey.

Authors:  Ulrike Ravens-Sieberer; Nora Wille; Michael Erhart; Susanne Bettge; Hans-Ulrich Wittchen; Aribert Rothenberger; Beate Herpertz-Dahlmann; Franz Resch; Heike Hölling; Monika Bullinger; Claus Barkmann; Michael Schulte-Markwort; Manfred Döpfner
Journal:  Eur Child Adolesc Psychiatry       Date:  2008-12       Impact factor: 4.785

8.  The Belmont Report. Ethical principles and guidelines for the protection of human subjects of research.

Authors: 
Journal:  J Am Coll Dent       Date:  2014

9.  Interrater reliability: the kappa statistic.

Authors:  Mary L McHugh
Journal:  Biochem Med (Zagreb)       Date:  2012       Impact factor: 2.313

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.